GPS Wealth Strategies Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $471K | Sell |
1,059
-10
| -0.9% | -$4.45K | 0.05% | 189 |
|
|
2025
Q1 | $518K | Sell |
1,069
-44
| -4% | -$21.3K | 0.07% | 164 |
|
|
2024
Q4 | $448K | Sell |
1,113
-87
| -7% | -$35K | 0.06% | 185 |
|
|
2024
Q3 | $558K | Buy |
1,200
+72
| +6% | +$33.5K | 0.07% | 166 |
|
|
2024
Q2 | $529K | Buy |
1,128
+351
| +45% | +$165K | 0.08% | 154 |
|
|
2024
Q1 | $325K | Buy |
777
+438
| +129% | +$183K | 0.05% | 197 |
|
|
2023
Q4 | $138K | Buy |
339
+46
| +16% | +$18.7K | 0.03% | 297 |
|
|
2023
Q3 | $102K | Buy |
293
+3
| +1% | +$1.04K | 0.02% | 359 |
|
|
2023
Q2 | $102K | Hold |
290
| – | – | 0.02% | 365 |
|
|
2023
Q1 | $91.4K | Buy |
+290
| New | +$91.4K | 0.02% | 366 |
|
|
2022
Q4 | – | Sell |
-172
| Closed | -$50K | – | 1060 |
|
|
2022
Q3 | $50K | Buy |
172
+23
| +15% | +$6.69K | 0.01% | 432 |
|
|
2022
Q2 | $42K | Hold |
149
| – | – | 0.01% | 478 |
|
|
2022
Q1 | $39K | Buy |
149
+76
| +104% | +$19.9K | 0.01% | 465 |
|
|
2021
Q4 | $16K | Buy |
73
+48
| +192% | +$10.5K | ﹤0.01% | 643 |
|
|
2021
Q3 | $5K | Buy |
+25
| New | +$5K | ﹤0.01% | 846 |
|